申请人:CLARIANT INT LTD
公开号:WO2012013301A1
公开(公告)日:2012-02-02
The invention relates to compounds of formula (I): R0 signifies a C1 to C4 alkyl group, R1 signifies CN or CONH2, R2 signifies a secondary or tertiary amino group, R3 signifies a secondary or tertiary amino group, BR is a bridge of the formula -A-B-A- wherein A is substituted phenyl or substituted naphthyl or unsubstituted phenyl or unsubstituted naphthyl, and B is a bivalent group of the formula -SO2-, -CONH-, -HNCO-, -SO2NH- or -HNSO2-, with the proviso that the compounds of formula (I) bear at least one anionic substituent.
该发明涉及式(I)的化合物:R0表示C1到C4的烷基基团,R1表示CN或CONH2,R2表示次级或三级胺基团,R3表示次级或三级胺基团,BR是式-A-B-A-的桥,其中A是取代苯基或取代萘基或未取代苯基或未取代萘基,B是式-SO2-、-CONH-、-HNCO-、-SO2NH-或-HNSO2-的二价基团,但化合物的式(I)至少带有一个阴离子取代基。